ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 105 filers reported holding ARATANA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $622,000 | +60.7% | 120,635 | +12.3% | 0.00% | – |
| Q1 2019 | $387,000 | -41.2% | 107,400 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $658,000 | +4.9% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $627,000 | +37.5% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $456,000 | -3.8% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $474,000 | -16.1% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $565,000 | -14.1% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $658,000 | -15.3% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $777,000 | +36.6% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $569,000 | -26.2% | 107,400 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $771,000 | +110.1% | 107,400 | +356.2% | 0.00% | – |
| Q2 2014 | $367,000 | -31.7% | 23,542 | -37.5% | 0.00% | -100.0% |
| Q1 2014 | $537,000 | – | 37,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,184,942 | $31,784,000 | 4.70% |
| AWM Investment Company, Inc. | 1,562,517 | $9,578,000 | 1.67% |
| Opaleye Management Inc. | 420,000 | $2,574,000 | 0.91% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 0.75% |
| GENERAL AMERICAN INVESTORS CO INC | 867,600 | $5,318,000 | 0.50% |
| Grandeur Peak Global Advisors, LLC | 538,363 | $3,300,000 | 0.50% |
| Redmond Asset Management, LLC | 55,941 | $343,000 | 0.16% |
| WOODSTOCK CORP | 88,303 | $541,000 | 0.10% |
| CADENCE CAPITAL MANAGEMENT LLC | 173,808 | $1,065,000 | 0.07% |
| Sheaff Brock Investment Advisors, LLC | 71,000 | $435,000 | 0.06% |